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Abstract
Background: Patterns of methicillin-resistant S. aureus (MRSA) nasal carriage over time and across the continuum of care
settings are poorly characterized. Knowledge of prevalence rates and outcomes associated with MRSA nasal carriage
patterns could help direct infection prevention strategies. The VA integrated health-care system and active surveillance
program provides an opportunity to delineate nasal carriage patterns and associated outcomes of death, infection, and
conversion in carriage.
Methods/Findings: We conducted a retrospective cohort study including all patients admitted to 5 acute care VA hospitals
between 2008–2010 who had nasal MRSA PCR testing within 48 hours of admission and repeat testing within 30 days. The
PCR results were used to define a baseline nasal carriage pattern of never, intermittently, or always colonized at 30 days
from admission. Follow-up was up to two years and included acute, long-term, and outpatient care visits. Among 18,038
patients, 91.1%, 4.4%, and 4.6% were never, intermittently, or always colonized at the 30-day baseline. Compared to non-
colonized patients, those who were persistently colonized had an increased risk of death (HR 2.58; 95% CI 2.18;3.05) and
MRSA infection (HR 10.89; 95% CI 8.6;13.7). Being in the non-colonized group at 30 days had a predictive value of 87% for
being non-colonized at 1 year. Conversion to MRSA colonized at 6 months occurred in 11.8% of initially non-colonized
patients. Age .70 years, long-term care, antibiotic exposure, and diabetes identified .95% of converters.
Conclusions: The vast majority of patients are not nasally colonized with MRSA at 30 days from acute hospital admission.
Conversion from non-carriage is infrequent and can be risk-stratified. A positive carriage pattern is strongly associated with
infection and death. Active surveillance programs in the year following carriage pattern designation could be tailored to
focus on non-colonized patients who are at high risk for conversion, reducing universal screening burden.
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Introduction
Nasal colonization with S. aureus is a dynamic process, with gain
and loss of carriage associated with a combination of factors [1].
Once a person becomes colonized with S. aureus, the risk of
infection increases and remains persistently elevated [2,3,4,5].
Grossly, S. aureus carriage can be divided into patterns of never
colonized, always colonized, or intermittently colonized [6]. The
distribution of these patterns is relatively well established for
methicillin-sensitive S. aureus (MSSA) but not for methicillin-
resistant S. aureus (MRSA), particularly in the era of community
MRSA. A number of hospitals and other health care facilities in
the US test patients for nasal MRSA colonization, however, most
only assess carriage when patients are admitted to an intensive
care unit. Thus, changes in colonization during hospitalization, in
the community, and subsequent hospitalization at another facility
are not detected [7]. Understanding the natural history of MRSA
carriage patterns over time as well as the associated risks of
infection and death is important for directing infection prevention
activities such as active surveillance and decolonization programs
[8].
The Department of Veterans Affairs (VA) has been performing
active surveillance for nasal MRSA carriage since late 2007.
Unique features of this program include multiple assessments
during a single hospitalization (admission, unit transfer, and
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veterans return to the VA integrated health-care system for care. A
recent report demonstrated reductions in MRSA infections on
a national level in association with this program, but did not report
individual risk-adjusted patient-level outcomes [9]. The current
study aims to characterize patterns of nasal MRSA carriage
among a large cohort of individual patients and evaluate
associated risks for conversion, infection, and death. We demon-
strate that the majority of hospitalized patients are non-carriers of
nasal MRSA and the small proportion likely to convert to
a colonized state can be identified by clinical criteria, suggesting
screening programs can be reduced in scope to focus on these
patients. Patients who are colonized have significantly elevated
risks of MRSA infection and death compared to non-colonized
patients, even after adjusting for health care exposure and co-
morbidities.
Methods
Ethics Statement
VA Boston IRB approval was obtained prior to data extraction
and analysis. As per IRB approval, written informed consent was
waived as this was a retrospective database only study utilizing the
existing electronic health record and the research would not be
practicable without the waiver.
Study Population
We conducted a retrospective cohort study of patients admitted
to any of the 5 acute care hospitals in the New England Veterans
Integrated Service Network (VISN 1) between January 2008 and
December 2010. VISN 1 consists of 1,084 inpatient beds and cares
for approximately 240,000 unique patients annually in the states of
Maine, New Hampshire, Vermont, Rhode Island, Massachusetts,
and Connecticut. Data from the acute care hospitals, 3 long term
care facilities, and all associated VA outpatient community clinics
in VISN 1 were captured.
All patients who had an acute care admission, a nasal PCR
screening test for MRSA performed within 48 hours of the
admission (index admission), and at least one more nasal screen
performed within the next 30 days were eligible for study
inclusion. Index admissions were censored at 6/30/2010 to allow
a minimum of 6 months of follow-up time. Patients were followed
for a maximum of 2 years, or until the date of death, a gap of 18
months without VA health care use, or the study end date (12/31/
2010).
Carriage Pattern Definitions
The GeneXpert MRSA PCR assay (Cepheid, Sunnyvale, CA) is
used to test for nasal MRSA carriage at each hospital. Nasal
carriage patterns were designated as never (no nasal swabs
positive), always (.80% of nasal swabs positive), or intermittent
(.1 but less than 80% of swabs positive) and were determined on
the basis of all available nasal PCR test results within the first 30
day period of the index admission. The carriage patterns were
determined during two different time periods. The first used all
screen results from the first 30-days. In order to account for the
changes in carriage pattern over the study period, a second
carriage pattern designation was determined using all screen
results from the entire follow-up window (dynamic carriage
pattern). Patients were removed from the never colonized group
and excluded from the study if they had a positive clinical culture
for MRSA in the previous year. Outcomes were assessed for both
the 30-day carriage pattern as well as the dynamic carriage
pattern. We performed a validation of the 30-day PCR pattern
rule by evaluating concordance with carriage patterns in patients
who had 5 or more swabs within a 1 year period (including the
swabs performed in the first 30 days) because a rule for
determining S. aureus carriage pattern has not been validated
using PCR [10].
Data Collection
The electronic health record was used to capture antibiotic and
health-care exposures, co-morbidities, and outcomes. Clinical
cultures for MRSA and MSSA were extracted from the VISN 1
data warehouse. Any positive culture from blood or bone was
coded as infection. Positive cultures from wounds, skin, sputum,
urine or other non-sterile sites were coded as infection if there was
an active antimicrobial agent administered within 5 days of the
culture result. Data from all inpatient and outpatient encounters
were included.
Statistical Analysis
Baseline characteristics are described by frequencies and
proportions stratified by the 30-day carriage pattern designation.
Chi-squared tests were used to evaluate clinical parameters among
patients in each of the three carriage pattern groups. A multi-
variable logistic regression was used to assess the effects of multiple
potential risk factors on the three categories of colonization status,
as well as to determine what risk factors predicted conversion to
MRSA colonized status during the six month period following
initial screening.
Cox proportional hazards models were used to assess time to
each of the three outcomes (death, first MRSA infection, and first
MSSA infection) among the three carriage groups. The models
were run twice for each outcome to allow a comparison of the 30-
day carriage pattern and the dynamic carriage pattern over the
study period. Cumulative incidence curves were generated to plot
the resulting survival for each outcome. SAS statistical software
was used for all programming with p-values of , 0.05 as
statistically significant.
Results
A total of 31,662 unique patients had 66,804 hospitalizations to
at least one of the 5 acute care hospitals over the 3-year study
period. A nasal MRSA PCR result was available within 2 days of
the index admission in 24,101 (76%) patients, and two or more
MRSA surveillance results were available over a 30 day period in
18,100 patients (Figure 1). Sixty-two patients were excluded
because they had a non-colonized carriage pattern but a positive
culture in the previous year, leaving 18,038 patients in the study
cohort. Consistent with the overall VISN 1 patient population,
96% of subjects were male and the mean age was 66.7 years
(Table 1). Among the 13,664 patients for whom race was
recorded, 12,466 (91.2%) were white and 7.9% were black.
Carriage Patterns at 30 Days
The proportions of patients categorized as never, intermittently,
or always colonized at the 30-day baseline were 91.1%, 4.4%, and
4.6%, respectively (Table 1). Patients in the never colonized group
were less likely to be over 70 years of age (39%) than intermittently
(47%) or always (54%) colonized patients (p ,.001, Chi square for
trend). A history of health care exposure in the past year, including
acute or long-term care admissions, was more frequent in always
colonized versus never colonized patients. A culture was positive
for MRSA in the previous year in less than 1% of the total cohort
and was present in 76 (9.3%) and 28 (3.5%) of patients in the
always and intermittent carriage pattern groups, respectively. Co-
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tus ulcer were each significantly increased in always compared to
intermittently and never colonized patients. A higher proportion of
patients in the always colonized group had received an antibiotic
in the previous 6 months, including MRSA active and non-active
agents. Fluoroquinolones were used twice as frequently in always
colonized compared with never colonized patients (Table 1).
In multivariate models, independent variables associated with
MRSA nasal carriage (intermittent or always) compared to non-
carriage at the 30-day baseline included advancing age, acute or
long-term care admission in the past year, diabetes mellitus, renal
disease (independent of dialysis), decubitus ulcer, and any
antibiotic use in the past 6 months (Table 2). The presence of
a decubitus ulcer was the strongest predictor of having a colonized
carriage pattern (OR 5.33, 95% CI 3.71;7.66).
Performance of the 30-day PCR Carriage Pattern at 1 Year
There were 4,972 patients with a carriage pattern designated at
30 days who had 5 or more nasal screens for MRSA performed
during the one year period from the index admission. Among the
4,415 patients with an initial non-colonized carriage pattern, 3,857
(87.4%) remained negative for nasal MRSA, 553 (12.5%) were
intermittently MRSA nasal positive, and 5 (0.1%) developed
persistent MRSA colonization. Thus, the 30-day non-colonized
carriage pattern had a specificity of 50% (558/1115) compared to
a 1-year pattern, but because of a high prevalence of the non-
colonized state, the positive predictive value was 87% (3857/4415)
for being non-colonized at one year. Movement from an
intermittent carriage pattern to an always pattern occurred in
39/304 (12.8%) patients and from always (more than 80% of
screens positive) to intermittent (less than 80% screens positive) in
80/253 (31.6%) of patients.
Conversion from a Non-colonized Carriage Pattern
Among 4597 patients who were non-colonized at 30 days and
had at least one re-screening performed in the following 6 months,
509 (11%) had a positive nasal PCR for MRSA. One to 25
screening tests were performed per person during the 6 months,
with no difference in the mean number of tests between carriage
patterns. An additional 33 (0.8%) patients had a conversion based
on a positive culture for MRSA during the same time period.
During the subsequent 6 months, an additional 8.5% of 2,496
patients with an initial non-colonized carriage pattern who were
not identified as converting in the first 6 months became positive
for MRSA. After adjusting for the number of swabs performed,
number of long term care admissions, days of inpatient care, and
co-morbidities, the predictors of conversion from never to
a colonized pattern included age greater than 70 years, long term
care admission in the previous year, and antibiotic use in the
follow-up period (MRSA-active as well as other) (table 3). There
was a trend for conversion in patients with diabetes (table 3). The
presence of age greater than 70, diabetes, long term care
admission in the year prior, or antibiotic use in the time from
initial carriage pattern designation identified more than 95% of
patients who were rescreened and converted over 6 months.
Algorithm for Reducing Screening
Applying the 4 clinical criteria to the 16,425 patients who were
not colonized at baseline identified 5,850 patients who comprised
a low risk for conversion group (figure 2). Among this low risk
group, 25 of 391 (6.4%) re-screened patients converted in the first
6 months and 36 of 698 (5.2%) converted in the second 6 months,
for a total of 61 patients (5.7% of 1,089 re-screened patients and
1% of the whole low risk group) converting to MRSA positive over
a one year period. Among patients with an initial non-colonized
carriage pattern who were not in the low risk group and were re-
screened, the rate of conversion was 11.5% in the first 6 months
and 9.7% in the second 6 months, for an annual conversion of
10.9% among 6,236 re-screened patients or 6.4% among the
entire ‘‘high risk’’ group. The number of screens that could be
avoided if the 5,850 low risk and 1,613 already colonized (793
intermittent + 820 always) groups were not re-screened is 7,463
(41% of the original cohort; figure 2).
Outcomes of Death and Infection
The outcomes of death and infection (MRSA and MSSA) were
evaluated based on the 30 day carriage pattern as well as the
dynamic carriage pattern over the study period. Death occurred in
1500 patients (8.4% of the study cohort), with an increasing rate
with higher carriage burden at the 30-day baseline; 7.6% of never
colonized, 15.0% of intermittently colonized, and 18.6% of always
colonized patients died during follow-up. The mean follow-up
time was 17.5, 16.5, and 17.2 months and the mean time to death
from initial screening was 4.7, 4.5, and 4.9 months, respectively, in
the never, intermittent and always colonized groups. Compared to
non-colonized patients, those with intermittent or always colo-
nized carriage patterns had a greater than 2-fold increased risk of
death (HR 2.09; 95% CI 1.73;2.53 and HR 2.58; 95% CI
2.18;3.05, respectively) (figure 3a). After accounting for age,
number of screening tests in the follow-up period, number of acute
care and long term care admissions, total acute care and long term
care hospital days, diabetes, renal disease, HIV infection,
decubitus ulcer, eczema, and antibiotic exposure, the risk of death
remained significantly elevated among always (HR 1.91; 95% CI
1.60;2.28) and intermittently colonized (HR 1.75; 95% CI
1.45;2.12) patients. When accounting for changes in carriage
pattern over the study period (the dynamic carriage pattern), the
adjusted risk of death was even higher among patients always
colonized as compared to patients remaining non-colonized (HR
2.44; 95% CI 2.04;2.91).
Figure 1. Flow Diagram. Derivation of the study cohort.
doi:10.1371/journal.pone.0053674.g001
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follow-up period, with 221 (1.36%), 73 (9.48%), and 106 (13.43%)
occurring in the non, intermittent, and always colonized 30-day
carriage pattern groups. The 400 MRSA infections in unique
patients occurred in blood (14.8%), bone (2.8%), abscess/fluid
(26.5%), respiratory (38%), skin and soft tissue (16.5%), and other
sites (1.3%). The mean follow-up time was 17.5, 15.2, and 15.6
months and the mean time to infection was 8.4, 5.0, and 6.1
months respectively among never, intermittently, and always
colonized groups. The risk of infection was more than 10 fold
greater among always colonized carriage pattern patients com-
pared to the non-colonized carriage pattern (HR 10.89; 95% CI
8.6; 13.72) (figure 3b). After controlling for health care exposures
and co-morbidities (same model as outlined above for death), the
risk of MRSA infection remained elevated among always (HR
6.88; 95% CI 5.38;8.80) and intermittently (HR 5.46; 95% CI
4.17;7.14) colonized patients. Accounting for the dynamic carriage
pattern (colonization occurring during follow-up), the adjusted risk
Table 1. Baseline Characteristics for Study Cohort by 30-Day Carriage Pattern.
Baseline Characteristic All Carriage Pattern During First 30-Days
N=18,038
n( % )
Never
n=16,425 (91.1)
n( % )
Intermittent
n=793 (4.4)
n( % )
Always
n=820 (4.6)
n( % )
Demographics
Male Sex 17,259 (95.7) 15,690 (95.5) 771 (97.2) 798 (97.3)
Age, Years, 71+ 7,211 (40.0) 6,397 (39.0) 374 (47.2) 440 (53.7)
Race: White 12,466 (69.1) 11,273 (68.6) 561 (70.7) 632 (77.1)
Black 1,078 (6.0) 984 (6.0) 49 (6.2) 45 (5.5)
Other 120 (0.67) 108 (0.66) ,11 (0.76) ,11 (0.73)
Missing 4,374 (24.3) 4,060 (24.7) 177 (22.3) 137 (16.7)
Health Care Exposure, Previous Year
Acute Care Admission 3,348 (18.6) 2,820 (17.2) 208 (26.2) 320 (39.0)
Long Term Care Admission 570 (3.2) 410 (2.5) 53 (6.7) 107 (13.1)
Outpatient Procedure 8,949 (49.6) 8,116 (49.4) 400 (50.4) 433 (52.8)
Inpatient Procedure 309 (1.7) 250 (1.5) 17 (2.1) 42 (5.1)
Dialysis 83 (0.46) 71 (0.43) ,11 (0.25) ,11 (1.2)
S. aureus cultures, Previous Year
MRSA Clinical Culture 104 (0.58) 0 (0.0) 28 (3.5) 76 (9.3)
MSSA Clinical Culture 224 (1.2) 190 (1.2) 16 (2.0) 18 (2.2)
Co-morbidities, Previous Year
Malignancy 3,276 (18.2) 2,940 (17.9) 170 (21.4) 166 (20.2)
Chronic lung disease 437 (2.4) 379 (2.3) 24 (3.0) 34 (4.2)
Diabetes mellitus 5,019 (27.8) 4,465 (27.2) 252 (31.8) 302 (36.8)
Renal disease 1,058 (5.9) 878 (5.4) 70 (8.8) 110 (13.4)
Liver disease 454 (2.5) 395 (2.4) 25 (3.2) 34 (4.2)
Skin disease 902 (5.0) 806 (4.9) 36 (4.5) 60 (7.3)
Decubitus Ulcer 137 (0.76) 72 (0.44) 24 (3.0) 41 (5.0)
Selected Antibiotics, Previous 6 months
Beta-lactams 2,498 (13.9) 2,144 (13.1) 135 (17.0) 219 (26.7)
Fluoroquinolone 1,899 (10.5) 1,623 (9.9) 119 (15.0) 157 (19.2)
Topical (mupirocin) 135 (0.75) 95 (0.58) 12 (1.5) 28 (3.4)
MRSA Active Antibiotic 1,177 (6.5) 982 (6.0) 60 (7.6) 135 (16.5)
Any Antibiotic 5,311 (29.4) 4,678 (28.5) 260 (32.8) 373 (45.5)
doi:10.1371/journal.pone.0053674.t001
Table 2. Multivariable model of risk factors for patients with
an always or intermittently colonized compared to a never
colonized nasal MRSA carriage pattern at 30 days.
Variable Odds Ratio 95% CI P Value
Age 70 or less 0.61 (0.54; 0.68) ,.001
Acute care/past year 1.77 (1.56; 2.01) ,.001
Long term care/past year 2.82 (2.28;3.49) ,.001
Diabetes 1.22 (1.09;1.37) ,.001
Renal Disease 1.47 (1.22;1.77) ,.001
Decubitus ulcer 5.33 (3.71;7.66) ,.001
Any antibiotic use/past 6
months
1.35 (1.21;1.51) ,.001
doi:10.1371/journal.pone.0053674.t002
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compared to those that remained in the non-colonized carriage
group (HR 17.02; 95% CI 12.91;22.44).
MSSA infections occurred in 536 patients and were most
common in the intermittent MRSA carriage pattern group (6.3%)
compared to the always (3.2%) and non-colonized (2.9%) groups.
The risk of infection with MSSA was significantly higher in
intermittently colonized as compared to non-colonized patients
(HR 2.36; 95% CI 1.76;3.16) but not in patients who were
persistently colonized with MRSA (figure 3c). In multivariable
analysis, the adjusted risk of MSSA infection remained signifi-
cantly elevated in patients who were intermittently colonized with
MRSA (HR 1.84; 95% CI 1.37;2.48). The adjusted risk of MSSA
infection was not significantly associated with patterns of nasal
MRSA carriage when accounting for the changes in carriage over
the study period.
Discussion
The VA MRSA Prevention Initiative, a bundle which includes
both horizontal and vertical measures, has been temporally
associated with significant reductions in hospital-associated MRSA
infections [9]. Universal active surveillance is a costly and
resource-intensive component of the program [11]. Some studies
have tried to identify a sub-group of patients who are at high risk
of being colonized to help develop targeted screening programs.
Table 3. Multivariable model of risk factors for conversion from a non-colonized nasal MRSA carriage pattern to colonized over the
next 6 months.
Variable Odds Ratio 95% CI P value
Age 70 or less 0.66 (0.54;0.80) ,.001
Number of swabs in follow-up period 1.10 (1.06;1.14) ,.001
Long term care/past year 2.64 (1.73;4.04) ,.001
Diabetes 1.20 (0.98;1.46) .08
MRSA active antibiotic in follow-up period 1.35 (1.11;1.65) .003
Other antibiotic in follow-up period 1.57 (1.19;2.07) .002
doi:10.1371/journal.pone.0053674.t003
Figure 2. Proposed Algorithm for Reducing Screening. Number of nasal MRSA screens avoided by application of the initial carriage pattern
and clinical criteria identifying patients at low risk for conversion.
doi:10.1371/journal.pone.0053674.g002
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low sensitivity, missing at least 25–30% of patients who are later
found to be colonized [12]. In the absence of robust algorithms to
support high-risk screening, universal surveillance has continued.
We employed a novel approach by identifying initial patterns of
nasal MRSA carriage and then developing an algorithm to reduce
screening based on eliminating further screens on patients already
colonized as well as those at low risk for conversion. Given that the
average prevalence of MRSA colonization on hospital admission
to an acute care VA hospital is 13%, the non-colonized group
represents the vast majority of hospitalized veterans [9]. Our study
demonstrates that only 11.8% of patients who have two or more
consecutive nasal PCR swabs that are negative for MRSA in a 30-
day period have a subsequent positive culture or swab result in the
following 6 months, despite re-admission to the hospital. The rate
of conversion over the next 6-month period is even lower, with an
additional 8.5% of screened patients becoming positive for MRSA.
Importantly, the conversion rates among the low risk sub-group
were only 5–6% over the same 6 month periods. Thus the vast
majority of patients at risk for becoming colonized with MRSA
can be identified based on their initial nasal carriage pattern and
four clinical criteria.
Patients who have a positive carriage pattern on the initial
hospitalization continue to carry MRSA either always or in-
termittently over long periods of time [13]. The benefit of repeated
MRSA screening in these patients is unclear, since most will not
have the consistently negative result over 3 consecutive tests in the
absence of antibiotic exposure that would be required to move the
patient out of the ‘‘MRSA-colonized’’ category. Annual repeat
assessments may be reasonable for assessing changes in carriage
pattern, particularly if MRSA colonization risk factors such as
antibiotic use are absent.
Future screening and infection prevention efforts should focus
on the group of patients with an initial negative MRSA carriage
pattern who do not meet criteria for being at low-risk for MRSA
conversion. Based on our results, patients who are in long term
care, greater than 70 years of age, have diabetes or antibiotic use
are at highest risk of conversion to a MRSA colonized pattern over
a 6 month period. These criteria identified 95% of patients who
converted from non-colonized to colonized in our cohort and
could be applied at the time of admission to help direct screening.
Although antibiotic use may be more reliably captured in health
care systems with robust and integrated electronic health records,
a four point algorithm is less complex than what other studies have
proposed and could be applied at the bedside [14]. If additional
surveillance tests were avoided for a year on patients who at 30
days were found to be always or intermittently colonized and on
patients who were not colonized and at low risk for conversion,
approximately 7,500 surveillance tests could be spared at the
VISN level. At an estimated cost of $30–$50 per test, this could
result in significant annual cost savings within our VISN ($300–
400 K) and nationally (millions) without adversely affecting the
main goal of active surveillance, detection of colonized patients not
known to have MRSA [11,15]. Other facilities considering active
MRSA nasal screening on admission due to financial pressure to
reduce in-hospital acquisition could potentially reduce their
screening burden by using this clinical tool. However, future
studies will be needed to evaluate generalizability to non-VA
settings and the feasibility and efficacy of implementing a testing
reduction tool.
Our study demonstrates that establishing a carriage pattern of
MRSA colonization is useful not only for developing targeted
screening programs, but also for predicting the risk of death and
MRSA infection. Previous studies have found that MRSA carriage
is a risk factor for subsequent infection, both in the immediate
period after acquisition of MRSA as well as among patients who
are carriers for over a year [4,8]. Most of these studies identified
patients based on cultures that were obtained for clinical purposes
rather than via active nasal screening. In one study of 591 patients
newly detected to have MRSA (94% had an infection or clinical
culture as the index event) on admission to a tertiary care center,
33% developed an MRSA infection in the following year. Thus,
clearly, among patients with a new MRSA infection or positive
clinical culture, subsequent infection and mortality rates are high.
Our data add to this concept by defining an infection and death
risk among patients with asymptomatic nasal colonization, both of
which occurred in a linearly increasing frequency with an
increasing burden of colonization (non-colonized, intermittent,
and always colonized patterns). The risk of infection in particular
markedly increased as the carriage pattern changed over the
follow-up period, with a more than double increased risk ratio in
patients who became colonized during follow-up. This association
warrants further evaluation for potentially modifiable pathways.
Whether strategies other than simple detection and isolation would
be useful in reducing infection risk in these patients remains an
area of active investigation.
The main limitation of our study is the potential misclassifica-
tion of patients who had fewer screening tests (less chance of
converting carriage pattern). To minimize bias in our findings, our
models are adjusted for the number of screening tests performed,
and we also did not perform a time to event analysis of conversion
since it greatly depended on repeat testing rather than a clinically
apparent event such as death or infection. The findings are derived
from a demographic representative of the Veteran population and
thus may not translate fully to other populations. The performance
of the reduced screening strategy based on carriage pattern and
risk for conversion merits continued evaluation over time and in
additional populations. We used an electronic definition of
infection that may have misclassified some positive cultures in
either direction. The infection rates generated using this electronic
definition, however, are similar to those reported by another study
that used a chart review-based infection definition [4]. Nasal only
screening could have missed some people who were carriers of
MRSA, but the rate of exclusive extra-nasal colonization is low in
this population [16,17]. We also did not account for MSSA
colonization or differences in virulence among nasal MRSA
isolates that could have impacted infection risk. Our recent
molecular evaluation of nasal MRSA and MSSA among newly
colonized veterans identified a low prevalence of USA300 and
Panton-Valentine Leukocidin (PVL) genes and no association
between USA300 MRSA carriage and subsequent infection risk
[13].
The greatest strength of our study compared to previous studies
of infection risk in colonized patients is the ability to capture data
Figure 3. Outcomes by Carriage Pattern. The time to (a) death, (b) MRSA infection, and (c) MSSA infection in patients who had a non-colonized,
intermittently colonized, or always colonized nasal carriage pattern at 30 days. The risk of death and of MRSA infection, adjusted for age, number of
screening tests in the follow-up period, number of acute care and long term care admissions, total acute care and long term care hospital days,
diabetes, renal disease, HIV infection, decubitus ulcer, eczema, and antibiotic exposure, was significantly higher among patients with a colonized
compared to non-colonized nasal carriage pattern.
doi:10.1371/journal.pone.0053674.g003
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tions over a broad geographic region over a 3 year period and
define patterns of nasal carriage rather than rely on a single
assessment. The VA is the largest integrated health care system in
the country with a robust electronic health record system,
enhancing the detection of events occurring over the continuum
of care, including all VA acute care hospitals in the region, long-
term care facilities, and the outpatient setting. Our data also have
the advantage of representing the real-practice setting, without
experimental interventions that may or may not be feasible within
current health care delivery systems. Also, we were not reliant on
ICD-9 coding for MRSA infections, which has been shown to be
a poor measure in VA-based studies [18].
Conclusions
The MRSA nasal carriage pattern based on at least 2 nasal
PCR screens within 30 days in acutely hospitalized patients is
a strong predictor of ongoing carriage (and non-carriage), MRSA
infection, and all-cause mortality. Our findings have significant
implications for future policy considerations regarding the highly
successful VA MRSA Prevention Initiative, providing evidence
that one of the most costly components, universal active
surveillance, could be targeted towards the group of patients most
likely to convert from negative to positive over a one year period.
The effectiveness and optimal implementation of this strategy
needs to be studied along with continued assessment of additional
activities aimed at reducing subsequent infections.
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